Cargando…

1-(4-Methoxy­phenyl­sulfon­yl)-5-methyl-5-phenyl­imidazolidine-2,4-dione

The title compound, C(17)H(16)N(2)O(5)S, crystallized in the chiral monoclinic space group P2(1), with two enanti­omeric mol­ecules (A and B) in the asymmetric unit. It is composed of a methyl­imidazolidine-2,4-dione unit substituted with a phenyl group and a 4-methoxy­phenyl­sulfonyl group. The ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Abid, Hameed, Shahid, Stoeckli-Evans, Helen
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2969567/
https://www.ncbi.nlm.nih.gov/pubmed/21583077
http://dx.doi.org/10.1107/S1600536809016092
Descripción
Sumario:The title compound, C(17)H(16)N(2)O(5)S, crystallized in the chiral monoclinic space group P2(1), with two enanti­omeric mol­ecules (A and B) in the asymmetric unit. It is composed of a methyl­imidazolidine-2,4-dione unit substituted with a phenyl group and a 4-methoxy­phenyl­sulfonyl group. The benzene ring mean planes are inclined to one another by 22.20 (14)° in mol­ecule A and by 15.82 (13)° in mol­ecule B. In the crystal structure, the A and B mol­ecules are linked by N—H⋯O hydrogen bonds, forming centrosymmetric dimers. A number of C—H⋯O inter­actions are also present in the crystal structure, leading to the formation of a three-dimensinoal network.